NuWave Investment Management’s AbbVie ABBV Stock Holding History

NuWave Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-439	Closed	-$49K	–	288
2021 Q2	$49K	Buy	+439	New	+$49.4K	0.05%	261
2020 Q4	–	Sell	-5,976	Closed	-$524K	–	325
2020 Q3	$524K	Buy	5,976 +3,274	+121%	+$308K	0.81%	27
2020 Q2	$246K	Sell	2,702 -2,295	-46%	-$202K	0.32%	91
2020 Q1	$381K	Sell	4,997 -3,712	-43%	-$316K	0.83%	22
2019 Q4	$771K	Buy	8,709 +7,884	+956%	+$655K	0.75%	32
2019 Q3	$61K	Buy	825 +684	+485%	+$46.9K	0.06%	236
2019 Q2	$10K	Sell	141 -3,136	-96%	-$246K	0.01%	348
2019 Q1	$264K	Buy	+3,277	New	+$268K	0.31%	114
2018 Q4	–	Sell	-8,241	Closed	-$779K	–	395
2018 Q3	$779K	Sell	8,241 -518	-6%	-$49.1K	1.17%	8
2018 Q2	$811K	Buy	+8,759	New	+$855K	1.06%	17
2018 Q1	–	Sell	-3,948	Closed	-$382K	–	227
2017 Q4	$382K	Buy	+3,948	New	+$372K	0.45%	89

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NuWave Investment Management's ABBV Position: Q3 2021 in Review

NuWave Investment Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 439 shares — an estimated $49K sold.

NuWave Investment Management first reported a position in ABBV in Q4 2017 and held it in 11 quarters. The position peaked at $811K in Q2 2018. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

NuWave Investment Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
NuWave Investment Management sold 439 AbbVie shares in Q3 2021, an estimated $49K.
NuWave Investment Management first reported a position in AbbVie in Q4 2017 and held it in 11 quarters.
NuWave Investment Management's AbbVie position peaked at $811K in Q2 2018.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on NuWave Investment Management's 13F filing for Q3 2021, filed 18 Oct 2021.